313 related articles for article (PubMed ID: 27019000)
1. Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C Disease.
Nicoli ER; Al Eisa N; Cluzeau CV; Wassif CA; Gray J; Burkert KR; Smith DA; Morris L; Cologna SM; Peer CJ; Sissung TM; Uscatu CD; Figg WD; Pavan WJ; Vite CH; Porter FD; Platt FM
PLoS One; 2016; 11(3):e0152007. PubMed ID: 27019000
[TBL] [Abstract][Full Text] [Related]
2. Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1.
Cluzeau CV; Watkins-Chow DE; Fu R; Borate B; Yanjanin N; Dail MK; Davidson CD; Walkley SU; Ory DS; Wassif CA; Pavan WJ; Porter FD
Hum Mol Genet; 2012 Aug; 21(16):3632-46. PubMed ID: 22619379
[TBL] [Abstract][Full Text] [Related]
3. Systemic administration of 2-hydroxypropyl-β-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function.
Lopez AM; Terpack SJ; Posey KS; Liu B; Ramirez CM; Turley SD
Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):780-7. PubMed ID: 25115571
[TBL] [Abstract][Full Text] [Related]
4. Identification of Niemann-Pick C1 disease biomarkers through sphingolipid profiling.
Fan M; Sidhu R; Fujiwara H; Tortelli B; Zhang J; Davidson C; Walkley SU; Bagel JH; Vite C; Yanjanin NM; Porter FD; Schaffer JE; Ory DS
J Lipid Res; 2013 Oct; 54(10):2800-14. PubMed ID: 23881911
[TBL] [Abstract][Full Text] [Related]
5. Amyloid-β metabolism in Niemann-Pick C disease models and patients.
Mattsson N; Olsson M; Gustavsson MK; Kosicek M; Malnar M; Månsson JE; Blomqvist M; Gobom J; Andreasson U; Brinkmalm G; Vite C; Hecimovic S; Hastings C; Blennow K; Zetterberg H; Portelius E
Metab Brain Dis; 2012 Dec; 27(4):573-85. PubMed ID: 22935999
[TBL] [Abstract][Full Text] [Related]
6. Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life.
Ramirez CM; Liu B; Taylor AM; Repa JJ; Burns DK; Weinberg AG; Turley SD; Dietschy JM
Pediatr Res; 2010 Oct; 68(4):309-15. PubMed ID: 20581737
[TBL] [Abstract][Full Text] [Related]
7. Visual evoked potentials of Niemann-Pick type C1 mice reveal an impairment of the visual pathway that is rescued by 2-hydroxypropyl-ß-cyclodextrin.
Palladino G; Loizzo S; Fortuna A; Canterini S; Palombi F; Erickson RP; Mangia F; Fiorenza MT
Orphanet J Rare Dis; 2015 Oct; 10():133. PubMed ID: 26458950
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of primidone in Niemann-Pick disease type C (NPC)-model cells and mice: Reduction of unesterified cholesterol levels in cells and extension of lifespan in mice.
Ashikawa H; Mogi H; Honda T; Nakamura H; Murayama T
Eur J Pharmacol; 2021 Apr; 896():173907. PubMed ID: 33503462
[TBL] [Abstract][Full Text] [Related]
9. Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann-Pick disease type C1 mice.
Williams IM; Wallom KL; Smith DA; Al Eisa N; Smith C; Platt FM
Neurobiol Dis; 2014 Jul; 67():9-17. PubMed ID: 24631719
[TBL] [Abstract][Full Text] [Related]
10. Altered levels and distribution of amyloid precursor protein and its processing enzymes in Niemann-Pick type C1-deficient mouse brains.
Kodam A; Maulik M; Peake K; Amritraj A; Vetrivel KS; Thinakaran G; Vance JE; Kar S
Glia; 2010 Aug; 58(11):1267-81. PubMed ID: 20607864
[TBL] [Abstract][Full Text] [Related]
11. Developmental delay in motor skill acquisition in Niemann-Pick C1 mice reveals abnormal cerebellar morphogenesis.
Caporali P; Bruno F; Palladino G; Dragotto J; Petrosini L; Mangia F; Erickson RP; Canterini S; Fiorenza MT
Acta Neuropathol Commun; 2016 Sep; 4(1):94. PubMed ID: 27586038
[TBL] [Abstract][Full Text] [Related]
12. Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression.
Davidson CD; Ali NF; Micsenyi MC; Stephney G; Renault S; Dobrenis K; Ory DS; Vanier MT; Walkley SU
PLoS One; 2009 Sep; 4(9):e6951. PubMed ID: 19750228
[TBL] [Abstract][Full Text] [Related]
13. Normalization of cholesterol homeostasis by 2-hydroxypropyl-β-cyclodextrin in neurons and glia from Niemann-Pick C1 (NPC1)-deficient mice.
Peake KB; Vance JE
J Biol Chem; 2012 Mar; 287(12):9290-8. PubMed ID: 22277650
[TBL] [Abstract][Full Text] [Related]
14. Relative acidic compartment volume as a lysosomal storage disorder-associated biomarker.
te Vruchte D; Speak AO; Wallom KL; Al Eisa N; Smith DA; Hendriksz CJ; Simmons L; Lachmann RH; Cousins A; Hartung R; Mengel E; Runz H; Beck M; Amraoui Y; Imrie J; Jacklin E; Riddick K; Yanjanin NM; Wassif CA; Rolfs A; Rimmele F; Wright N; Taylor C; Ramaswami U; Cox TM; Hastings C; Jiang X; Sidhu R; Ory DS; Arias B; Jeyakumar M; Sillence DJ; Wraith JE; Porter FD; Cortina-Borja M; Platt FM
J Clin Invest; 2014 Mar; 124(3):1320-8. PubMed ID: 24487591
[TBL] [Abstract][Full Text] [Related]
15. Hydroxypropyl-beta and -gamma cyclodextrins rescue cholesterol accumulation in Niemann-Pick C1 mutant cell via lysosome-associated membrane protein 1.
Singhal A; Szente L; Hildreth JEK; Song B
Cell Death Dis; 2018 Oct; 9(10):1019. PubMed ID: 30282967
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary abnormalities in animal models due to Niemann-Pick type C1 (NPC1) or C2 (NPC2) disease.
Roszell BR; Tao JQ; Yu KJ; Gao L; Huang S; Ning Y; Feinstein SI; Vite CH; Bates SR
PLoS One; 2013; 8(7):e67084. PubMed ID: 23843985
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Two Liver Treatment Strategies in a Mouse Model of Niemann-Pick-Disease Type C1.
Ebner L; Gläser A; Bräuer A; Witt M; Wree A; Rolfs A; Frank M; Vollmar B; Kuhla A
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587349
[TBL] [Abstract][Full Text] [Related]
18. Ontogenic changes in lung cholesterol metabolism, lipid content, and histology in mice with Niemann-Pick type C disease.
Ramirez CM; Lopez AM; Le LQ; Posey KS; Weinberg AG; Turley SD
Biochim Biophys Acta; 2014 Jan; 1841(1):54-61. PubMed ID: 24076310
[TBL] [Abstract][Full Text] [Related]
19. Intracerebroventricular Treatment with 2-Hydroxypropyl-β-Cyclodextrin Decreased Cerebellar and Hepatic Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Expression in Niemann-Pick Disease Type C Model Mice.
Fukaura M; Ishitsuka Y; Shirakawa S; Ushihama N; Yamada Y; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Arima H; Kurauchi Y; Seki T; Katsuki H; Higaki K; Matsuo M; Irie T
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466390
[TBL] [Abstract][Full Text] [Related]
20. 2-Hydroxypropyl-β-cyclodextrin is the active component in a triple combination formulation for treatment of Niemann-Pick C1 disease.
Davidson J; Molitor E; Moores S; Gale SE; Subramanian K; Jiang X; Sidhu R; Kell P; Zhang J; Fujiwara H; Davidson C; Helquist P; Melancon BJ; Grigalunas M; Liu G; Salahi F; Wiest O; Xu X; Porter FD; Pipalia NH; Cruz DL; Holson EB; Schaffer JE; Walkley SU; Maxfield FR; Ory DS
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1545-1561. PubMed ID: 31051283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]